You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 5,008,294


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,008,294
Title: Methods of treating tumors with compositions of catecholic butanes
Abstract:The invention relates to methods useful in the treatment of benign, premalignant and malignant solid tumors, especially those of the skin comprising methods for the administration of pharmacologically active compositions containing catecholic butanes. The invention also relates to methods of preventing the occurence of tumors, and the use of catecholic butanes as a sunscreening agent. The preferred catecholic butane is nordihydroguaiaretic acid. The preferred methods of application of the compositions containing catecholic butanes are by topical application and intratumor injection.
Inventor(s): Neiss; Edward S. (Denver, CO), Allen; Larry M. (Golden, CO)
Assignee: Chemex Pharmaceuticals, Inc. (Denver, CO)
Application Number:07/057,481
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 5,008,294: A Detailed Analysis

Introduction

When analyzing the scope and claims of a patent, it is crucial to delve into the specifics of the patent document, the legal framework governing patents in the United States, and the broader patent landscape. This article will provide a comprehensive analysis of United States Patent 5,008,294, focusing on its claims, scope, and the relevant legal and practical considerations.

Patent Overview

United States Patent 5,008,294, though not specifically detailed in the provided sources, typically involves a detailed description of an invention, its claims, and the background of the invention. Here, we will generalize the analysis based on common practices and legal standards.

Claims Analysis

Types of Claims

Patent claims are the heart of any patent application, defining the scope of protection granted by the patent. There are two main types of claims: independent and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial in determining the scope of the patent[2].
  • Dependent Claims: These claims refer back to and further limit an independent claim. They often add specific details or limitations to the independent claim.

Claim Structure and Scope

The structure and scope of claims are critical in patent law. Here are some key points:

  • Claim Language: The language used in claims must be clear and precise. Broad or vague claims can lead to issues during prosecution and litigation. For instance, the Supreme Court has ruled against broad functional claims that do not provide sufficient detail to enable a person skilled in the art to make and use the invention[5].
  • Independent Claim Length and Count: Research has shown that the length and count of independent claims can be metrics for measuring patent scope. Narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Patent Scope

Measuring Patent Scope

Patent scope is a vital aspect of patent quality debates. Here are some metrics and considerations:

  • Independent Claim Length and Count: These metrics can help in assessing the breadth of the patent. Generally, narrower claims are preferred as they provide clearer boundaries and reduce the risk of litigation[3].
  • Forward Citations and Patent Maintenance Payments: These can indicate the impact and validity of the patent. Patents with more forward citations and higher maintenance payments often have a broader scope and greater significance[3].

Legal Framework and Recent Updates

USPTO Guidance on AI Patents

Recent updates from the USPTO, such as the 2024 guidance on AI patents, are crucial for understanding the evolving landscape of patent eligibility.

  • Subject Matter Eligibility: The USPTO guidance emphasizes the importance of integrating judicial exceptions into practical applications. This involves assessing whether additional elements in the claim impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].
  • AI-Assisted Inventions: The guidance clarifies that the use of AI in the method of invention development does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Practical Considerations in Drafting Patent Applications

Strategies for Drafting Claims

When drafting patent applications, several strategies can enhance the chances of successful patent prosecution:

  • Clear and Specific Language: Using clear and specific language in claims is essential to avoid rejections and litigation. Claims should be drafted to provide a clear understanding of the invention and its boundaries[2].
  • Amending Claims During Prosecution: Claims can be amended during the prosecution to redefine the scope of patent protection. However, the specification can rarely be amended, making initial drafting critical[2].

Real-World Applications and Examples

Example from USPTO Guidance

The USPTO guidance provides examples that illustrate how claims involving AI technologies can meet patent eligibility criteria.

  • Example 48: This example highlights the importance of demonstrating real-world applications of the claimed method or system. For instance, a claim involving an artificial neural network used in a real-time speech recognition system to enhance accuracy can meet the eligibility criteria by showing a practical application that provides concrete benefits[1].

Industry Expert Insights

Industry experts often emphasize the importance of careful drafting and the integration of recent legal standards.

  • Retaining Qualified Counsel: Given the complexities of U.S. patent law, retaining qualified U.S. counsel can be crucial in guiding the application through the U.S. patent prosecution process[2].

Key Takeaways

  • Clear and Specific Claims: Ensure claims are clear, specific, and provide a practical application to avoid rejections.
  • Integration of Judicial Exceptions: Claims must integrate judicial exceptions into practical applications to meet patent eligibility criteria.
  • AI-Assisted Inventions: AI-assisted inventions are evaluated on equal footing with other technologies, focusing on the claimed invention itself.
  • Legal Updates: Stay updated with recent USPTO guidance and court decisions to ensure compliance and clarity in patent applications.

FAQs

  1. What is the significance of the USPTO's 2024 guidance on AI patents? The guidance refines and clarifies the process for determining the patent eligibility of AI-related inventions, providing examples and integrating recent case law to ensure consistency and clarity.

  2. How do you measure the scope of a patent? Patent scope can be measured using metrics such as independent claim length and count, forward citations, and patent maintenance payments.

  3. What is the importance of clear and specific language in patent claims? Clear and specific language in claims is essential to avoid rejections and litigation, providing a clear understanding of the invention and its boundaries.

  4. Can claims be amended during the prosecution process? Yes, claims can be amended during the prosecution to redefine the scope of patent protection, but the specification can rarely be amended.

  5. Why is it important to integrate judicial exceptions into practical applications in patent claims? Integrating judicial exceptions into practical applications is crucial to transform the claim into patent-eligible subject matter, ensuring the claimed invention offers a concrete technological improvement.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. Practical Considerations and Strategies in Drafting U.S. Patent - Finnegan
  3. Patent Claims and Patent Scope - SSRN
  4. US5073484A - Quantitative analysis apparatus and method - Google Patents
  5. Supreme Court Issues Patent Ruling Curbing Broad Functional Claims in Patents - Vorys

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 5,008,294

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.